GBM is a very aggressive form of cancer. Life expectancy after diagnosis is measured in months. To screen a GBM patient and get them on trial is a challenge. Add the disruption to healthcare caused by covid and I think the time span to fully enrol the cohort is understandable.
Another test site has been added for thd next cohort, so hopefully that helps.
News on how the drug performed next.
Ann: Follow up period completed for 3rd cohort in CHM 1101 trial, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $12.99M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $949 | 312.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 70 | 67782438 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 91927011 | 27 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |